Insight Molecular Diagnostics IMDX Earnings Call Transcripts

NASDAQ IMDX
$2.49 +0.03 (+1.22%)
At close: Nov 6, 2026 · 4:00 PM EST
2 earnings calls on file for Insight Molecular Diagnostics, from Q1 2026 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Insight Molecular Diagnostics Q2 2026 Earnings Call

Aug 10, 2026 4,054 words · 18 min read
  • Josh RiggsPresident and CEO
  • Ekke SchutzChief Science Officer
  • Andrea JamesCFO
  • Gabrielle WoodyInvestor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Insight Molecular Diagnostics Earnings Call Transcripts

Calls2
LatestAug 10, 2026
SinceQ1 2026

Fiscal 2026

All 2 Insight Molecular Diagnostics transcripts Register to get access to Insight Molecular Diagnostics’s earnings call transcripts.